Camila V. Blair and Colleagues on The Association of CAD by Coronary CT Angiography and Cardiovascular Outcomes in Psoriatic Disease
Camila V. Blair, Postdoctoral Research Fellow at Brigham and Women’s Hospital, reposted from American Journal of Preventive Cardiology on LinkedIn:
”Our manuscript is out!
Thrilled to share our latest publication in the American Journal of Preventive Cardiology
Among patients with psoriatic disease (PsO) referred for coronary CT angiography (CCTA):
- Both non-obstructive and obstructive coronary artery disease (CAD) were highly prevalent and associated with a stepwise increase in major adverse cardiovascular events (MACE).
- Risk of MACE rose with increasing plaque burden, and obstructive CAD remained significantly associated with MACE after traditional CV risk factors adjustment.
- Participants with coronary plaque often had low estimated 10-year ASCVD risk scores, below thresholds for statin initiation, revealing a gap between traditional risk prediction and true atherosclerotic burden in individuals with psoriasis.
Our findings reinforce the need for interdisciplinary strategies for prevention, bridging dermatology, rheumatology, and cardiology, to better identify and manage cardiovascular risk in immune-mediated inflammatory diseases.
Grateful to collaborate with this incredible team led by Jonathan Aun, Ron Blankstein, Brittany Weber.”
Quoting American Journal of Preventive Cardiology‘s post:
”New study: Coronary CT angiography reveals that coronary artery disease is strongly linked to adverse cardiovascular outcomes in patients with psoriatic disease.”
Read the full article here.
Article: The Association of Coronary Artery Disease by Coronary CT Angiography and Cardiovascular Outcomes in Psoriatic Disease
Authors: Jonathan A. Aun, Daniel M. Huck, Stephanie A. Besser, Arthur Shiyovich, Milena Petranovic, Adam N. Berman, Camila Veronica Blair, Christos P. Kotanidis, Jon Hainer, Dave W. Biery, Nayruti Trivedi, Khaled Abdelrahman, Rhanderson Cardoso, Joseph Merola, Michael Garshick, Brian Ghoshhajra, Sandeep Hegdire, Marcelo Di Carli, Ron Blankstein, Brittany N. Weber
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 16, 2026, 16:06Katrina Louise Manalaysay: In Your 20s, You Might be Given the Opportunity to Donate Blood for the First Time
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?
-
Sep 16, 2026, 14:42Ruchi Punamia: Beyond the Blood Bank and The Clinical Impact of Apheresis
-
Sep 16, 2026, 14:06Kalyan Roy: Celebrating Apheresis, Advancing Care, Saving Lives
-
Sep 16, 2026, 13:38Andrew Zapfel: Advancing Sickle Cell Disease Care and Research
-
Sep 16, 2026, 13:30Thirunavukkarasu Angappan: Why Plasma-Derived Factor VIII Still Matters for Inhibitor Patients
-
Sep 16, 2026, 13:22Matthew Hazell: New BSH Guidance for Fetal, Neonatal and Paediatric Transfusion